CPHI
CHINA PHARMA HOLDINGS, INC.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies re-entered | Q2 2025(8Q snapshot) | 4Q | $0.00 | $0.74 | — |
| Citadel Advisors re-entered | Q2 2025(8Q snapshot) | 4Q | $0.00 | $0.74 | — |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at CHINA PHARMA HOLDINGS, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Oct 19, 2023 — the most recent Form 4 on file — not from today.
- Form 40001013762-23-005114Oct 19, 2023
- Form 40001213900-21-047830Sep 13, 2021
- Form 40001213900-21-001170Jan 8, 2021
- Form 40001010549-12-000445May 1, 2012
- Form 40001010549-11-000528May 27, 2011
- Form 40001010549-11-000526May 27, 2011
- Form 40001010549-11-000198Mar 2, 2011
- Form 40001010549-10-000745Nov 19, 2010
- Form 40001010549-10-000082Feb 10, 2010
- Form 40001010549-09-000685Oct 15, 2009
- Form 40001010549-07-000910Nov 8, 2007
- Form 40001010549-06-000620Sep 14, 2006
- Form 40001010549-06-000619Sep 14, 2006
- Form 40000899797-06-000189May 16, 2006
- Form 40001010549-05-000699Oct 4, 2005
Fundamentals
XBRL · CHINA PHARMA HOLDINGS, INC.Annual figures sourced directly from CHINA PHARMA HOLDINGS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for CHINA PHARMA HOLDINGS, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQUARTERLY REPORTMay 15, 2026
- 10-KANNUAL REPORTApr 1, 2026
- 8-KCURRENT REPORTMar 3, 2026
- 8-KCURRENT REPORTFeb 10, 2026
- 8-KCURRENT REPORTJan 6, 2026
- 8-KFORM 8-KDec 23, 2025
- 8-KCURRENT REPORTDec 10, 2025
- DEF 14ADEFINITIVE PROXY STATEMENTNov 14, 2025
- 10-QQUARTERLY REPORTNov 12, 2025
- 10-QQUARTERLY REPORTAug 14, 2025
- 10-QQUARTERLY REPORTMay 14, 2025
- 8-KCURRENT REPORTApr 4, 2025
- 10-KANNUAL REPORTMar 31, 2025
- 8-KCURRENT REPORTDec 26, 2024
- 8-KCURRENT REPORTDec 26, 2024
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | open | $1.04 | $0.74 | -29% |
| Renaissance Technologies | Q4 2025 | open | $1.52 | $0.74 | -51% |
| Citadel Advisors | Q3 2025 | Q1 2026 | $1.46 | $0.63 | -57% |
| Citadel Advisors | Q2 2025 | Q3 2025 | $0.00 | — | +0% |
| Renaissance Technologies | Q2 2025 | Q3 2025 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.